RSV infection that is managed via primary care in children under 5 years of age leads to a substantial burden for families, primary care resources, and society.

Vaccines are designed to guard babies, toddlers, and older children against a whole range of serious and potentially deadly ...

Learn how analytical methodologies can be used to identify RSV pre- and post-fusion proteins for vaccine development.

In the US alone, RSV infections account for approximately 177,000 hospitalisations and 14,000 deaths each year among older adults, according to Pfizer. For children younger than five years old in ...

The respiratory syncytial virus (RSV) vaccine produced strong immune responses in older adults during its first two seasons of use, according to a new study.

Approximately 1% to 3% of children under 12 months ... births and neonatal deaths. Pfizer filed for Japanese approval of Abrysvo for the prevention of RSV disease in the older adult setting ...

Revenue for Arexvy and Abrysvo fell sharply year over year in the fourth quarter due to narrower U.S. guidelines for their ...

Vincenza Snow, MD, Senior Director, Pfizer Medical Affairs joined us to talk about RSV today. RSV (respiratory syncytial virus) is a highly contagious respiratory virus, meaning it can spread ...

Sales of both GSK’s and Pfizer’s vaccines for respiratory syncytial virus dropped significantly in the last three months of 2024, compared the same period one year before. In a earnings report ...